dc.contributor.author | Temperley Matilda. | |
dc.contributor.author | Mueller Dirk H. | |
dc.contributor.author | Njagi J Kiambo. | |
dc.contributor.author | Akhwale Willis. | |
dc.contributor.author | Clarke Siân E. | |
dc.contributor.author | Jukes Matthew CH. | |
dc.contributor.author | Estambale Benson B. | |
dc.contributor.author | Brooker Simon. | |
dc.date.accessioned | 2013-03-19T16:14:15Z | |
dc.date.available | 2013-03-19T16:14:15Z | |
dc.date.issued | 2008-09-30 | |
dc.identifier.citation | Malar J. 2008 Sep 30;7:196. doi: 10.1186/1475-2875-7-196. | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/18826594 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/14762 | |
dc.description.abstract | Abstract
Background
Awareness of the potential impact of malaria among school-age children has stimulated investigation into malaria interventions that can be delivered through schools. However, little evidence is available on the costs and cost-effectiveness of intervention options. This paper evaluates the costs and cost-effectiveness of intermittent preventive treatment (IPT) as delivered by teachers in schools in western Kenya.
Methods
Information on actual drug and non-drug associated costs were collected from expenditure and salary records, government budgets and interviews with key district and national officials. Effectiveness data were derived from a cluster-randomised-controlled trial of IPT where a single dose of sulphadoxine-pyrimethamine and three daily doses of amodiaquine were provided three times in year (once termly). Both financial and economic costs were estimated from a provider perspective, and effectiveness was estimated in terms of anaemia cases averted. A sensitivity analysis was conducted to assess the impact of key assumptions on estimated cost-effectiveness.
Results
The delivery of IPT by teachers was estimated to cost US$ 1.88 per child treated per year, with drug and teacher training costs constituting the largest cost components. Set-up costs accounted for 13.2% of overall costs (equivalent to US$ 0.25 per child) whilst recurrent costs accounted for 86.8% (US$ 1.63 per child per year). The estimated cost per anaemia case averted was US$ 29.84 and the cost per case of Plasmodium falciparum parasitaemia averted was US$ 5.36, respectively. The cost per case of anaemia averted ranged between US$ 24.60 and 40.32 when the prices of antimalarial drugs and delivery costs were varied. Cost-effectiveness was most influenced by effectiveness of IPT and the background prevalence of anaemia. In settings where 30% and 50% of schoolchildren were anaemic, cost-effectiveness ratios were US$ 12.53 and 7.52, respectively.
Conclusion
This study provides the first evidence that IPT administered by teachers is a cost-effective school-based malaria intervention and merits investigation in other settings. | |
dc.title | Costs and cost-effectiveness of delivering intermittent preventive treatment for malaria through schools in western Kenya | |
dc.type | Journal Article | |
dc.date.updated | 2013-03-19T16:14:15Z | |
dc.description.version | Peer Reviewed | |
dc.language.rfc3066 | en | |
dc.rights.holder | Matilda Temperley et al.; licensee BioMed Central Ltd. | |